Search

Search Constraints

You searched for: Author/Creator Trouw, L. A.

Search Results

2. Anti–Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis—A Replication Study in Three Cohorts: Comment on the Article by Truchetet et al. Issue 12 (27th October 2018)

3. Anti–Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis—A Replication Study in Three Cohorts: Comment on the Article by Truchetet et al. Issue 12 (27th October 2018)

4. Carbamylation reduces the capacity of IgG for hexamerization and complement activation. (5th January 2020)

5. Genetic variants in the region of the C1q genes are associated with rheumatoid arthritis. (6th June 2013)

7. Role of Anti–Carbamylated Protein Antibodies Compared to Anti–Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First‐Degree Relatives, and Healthy Controls. Issue 9 (25th August 2016)

8. Role of Anti–Carbamylated Protein Antibodies Compared to Anti–Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First‐Degree Relatives, and Healthy Controls. Issue 9 (September 2016)

10. Serum autoantibodies directed against transglutaminase‐2 have a low avidity compared with alloantibodies against gliadin in coeliac disease. (July 2014)